These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 971520)

  • 1. A comparison of the sulphite and thrombin methods for measuring fibrinogen concentration of plasma from patients undergoing thrombolytic therapy.
    Lane DA; Rampling MW; Kakkar VV
    Clin Chim Acta; 1976 Aug; 71(1):15-9. PubMed ID: 971520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sulphite precipitation method for fibrinogen measurement; its use on small samples in the presence of fibrinogen degradation products.
    Rampling MW; Gaffney PJ
    Clin Chim Acta; 1976 Feb; 67(1):43-52. PubMed ID: 1253452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent plasminogen-streptokinase treatment of deep vein thrombosis.
    Scully MF; Lane DA; Sagar S; Thomas DP; Kakkar VV
    Thromb Haemost; 1977 Feb; 37(1):162-9. PubMed ID: 138963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated nephelometry of fibrinogen: analytical performance and observations during thrombolytic therapy.
    Hoffmann JJ; Verhappen MA
    Clin Chem; 1988 Oct; 34(10):2135-40. PubMed ID: 3168233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SDS polyacrylamide gel characterization of serum FDP produced in response to ancrod and streptokinase/plasminogen infusion in man.
    Lane DA; Robbins A; Rampling MW; Kakkar VV
    Br J Haematol; 1977 May; 36(1):137-48. PubMed ID: 871418
    [No Abstract]   [Full Text] [Related]  

  • 6. New method for determining thrombin-clottable fibrinogen.
    Frigola A; Angeloni S; Cerqueti AR
    Clin Chem; 1977 Nov; 23(11):2103-6. PubMed ID: 912875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of fibrinogen concentration in blood plasma by the sulfite precipitation method].
    Tsariuk LA; Rybachuk VN; Shevchenko LI; Tolstykh VM
    Vopr Med Khim; 1979; 25(1):97-101. PubMed ID: 425377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct determination of plasma fibrinogen levels by heat precipitation. A comparison of the technique against thrombin clottable fibrinogen with spectrophotometry and radial immuno-diffusion.
    Desvignes P; Bonnet P
    Clin Chim Acta; 1981 Feb; 110(1):9-17. PubMed ID: 6783348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic treatment by infusion of streptokinase-plasminogen-complex (activator): laboratory effects.
    Martin H; Auel H; Riedel C
    Behring Inst Mitt; 1986 Feb; (79):263-71. PubMed ID: 2424424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biologic data furnished by the experience of thrombolytic treatments with streptokinase].
    Samama M; Yver J; Casubolo L; Soria J; Bousser J
    Nouv Rev Fr Hematol; 1968; 8(1):84-92. PubMed ID: 4232155
    [No Abstract]   [Full Text] [Related]  

  • 11. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP; Hanssen M
    Drugs; 1987; 33 Suppl 3():247-52. PubMed ID: 2445540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic versus fibrinogenolytic activity of rt-PA and streptokinase in patients with acute myocardial infarction.
    Prisco D; Bonechi F; Scarti L; Tramontana M; Abbate R; Gensini GF
    Angiology; 1990 Aug; 41(8):616-20. PubMed ID: 2117862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of currently available methods for plasma fibrinogen.
    Exner T; Burridge J; Power P; Rickard KA
    Am J Clin Pathol; 1979 May; 71(5):521-7. PubMed ID: 572134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of thrombosis by sequential therapy with ancrod followed by streptokinase. Clinical pharmacology and rheology.
    Forbes CD; Barbenell J; Prentice CR
    Haemostasis; 1976; 5(6):348-54. PubMed ID: 1017726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
    Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptokinase induced defibrination assessed by thrombin time: effects on residual coronary stenosis and left ventricular ejection fraction.
    Ranjadayalan K; Stevenson R; Marchant B; Umachandran V; Davies SW; Syndercombe-Court D; Gutteridge CN; Timmis AD
    Br Heart J; 1992 Aug; 68(2):171-5. PubMed ID: 1389732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepant fibrinogen values during thrombolytic therapy. Comparison of aca and Data-Fi results using immunofixation. Electrophoresis as a reference.
    Walker AN; Pope WT
    Am J Clin Pathol; 1985 Oct; 84(4):485-9. PubMed ID: 4036879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
    Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD
    Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.
    HAWKEY CM; STAFFORD JL
    J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.